Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 4
1995 2
1996 4
1997 5
1998 4
1999 4
2000 4
2001 6
2002 9
2003 11
2004 5
2005 3
2006 6
2007 4
2008 5
2009 4
2010 4
2011 11
2012 8
2013 7
2014 5
2015 11
2016 12
2017 10
2018 5
2019 6
2020 8
2021 8
2022 4
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

165 results
Results by year
Filters applied: . Clear all
Page 1
Cytomegalovirus breakthrough and resistance during letermovir prophylaxis.
Perchetti GA, Biernacki MA, Xie H, Castor J, Joncas-Schronce L, Ueda Oshima M, Kim Y, Jerome KR, Sandmaier BM, Martin PJ, Boeckh M, Greninger AL, Zamora D. Perchetti GA, et al. Among authors: boeckh m. Bone Marrow Transplant. 2023 Jan 24. doi: 10.1038/s41409-023-01920-w. Online ahead of print. Bone Marrow Transplant. 2023. PMID: 36693927
Letermovir is a relatively new antiviral for prophylaxis against cytomegalovirus (CMV) after allogeneic hematopoietic cell transplantation (HCT). ...
Letermovir is a relatively new antiviral for prophylaxis against cytomegalovirus (CMV) after allogeneic hematopoietic cell transplant …
How I Prevent Viral Reactivation in High-risk Patients.
Dadwal SS, Papanicolaou G, Boeckh M. Dadwal SS, et al. Among authors: boeckh m. Blood. 2022 Dec 9:blood.2021014676. doi: 10.1182/blood.2021014676. Online ahead of print. Blood. 2022. PMID: 36493341
High quality evidence exists for the effective prevention for herpes simplex virus (HSV), varicella zoster virus (VZV), and cytomegalovirus (CMV) infection and disease. Fewer data are available on the effective prevention of human herpesvirus 6 (HHV-6), Epstein-Barr virus …
High quality evidence exists for the effective prevention for herpes simplex virus (HSV), varicella zoster virus (VZV), and cytomegalovir …
Clinical and Economic Burden of Multiple Double-Stranded DNA Viral Infections after Allogeneic Hematopoietic Cell Transplantation.
Hill JA, Moon SH, Chandak A, Zhang Z, Boeckh M, Maziarz RT. Hill JA, et al. Among authors: boeckh m. Transplant Cell Ther. 2022 Sep;28(9):619.e1-619.e8. doi: 10.1016/j.jtct.2022.06.016. Epub 2022 Jun 25. Transplant Cell Ther. 2022. PMID: 35764288 Free article.
Patients who underwent allo-HCT between 2012 and 2017 were identified from a US open-source claims database (Decision Resource Group Real-World Evidence Data Repository; n = 13,363) and categorized according to the presence or absence of dsDNA viral infection, defined as having 1 …
Patients who underwent allo-HCT between 2012 and 2017 were identified from a US open-source claims database (Decision Resource Group Real-Wo …
Convergent clonal selection of donor- and recipient-derived CMV-specific T cells in hematopoietic stem cell transplant patients.
Erickson JR, Stevens-Ayers T, Mair F, Edmison B, Boeckh M, Bradley P, Prlic M. Erickson JR, et al. Among authors: boeckh m. Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):e2117031119. doi: 10.1073/pnas.2117031119. Proc Natl Acad Sci U S A. 2022. PMID: 35105810 Free PMC article.
A unique cohort of nonmyeloablative hematopoietic stem cell transplant patients allowed us to assess T cell competition in response to cytomegalovirus (CMV) reactivation, which was documented with detailed virology data. ...
A unique cohort of nonmyeloablative hematopoietic stem cell transplant patients allowed us to assess T cell competition in response to cy …
Mathematical Modeling of Within-Host, Untreated, Cytomegalovirus Infection Dynamics after Allogeneic Transplantation.
Duke ER, Boshier FAT, Boeckh M, Schiffer JT, Cardozo-Ojeda EF. Duke ER, et al. Among authors: boeckh m. Viruses. 2021 Nov 16;13(11):2292. doi: 10.3390/v13112292. Viruses. 2021. PMID: 34835098 Free PMC article. Clinical Trial.
Cytomegalovirus (CMV) causes significant morbidity and mortality in recipients of allogeneic hematopoietic cell transplantation (HCT). ...
Cytomegalovirus (CMV) causes significant morbidity and mortality in recipients of allogeneic hematopoietic cell transplantation (HCT) …
American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation.
Hakki M, Aitken SL, Danziger-Isakov L, Michaels MG, Carpenter PA, Chemaly RF, Papanicolaou GA, Boeckh M, Marty FM. Hakki M, et al. Among authors: boeckh m. Transplant Cell Ther. 2021 Sep;27(9):707-719. doi: 10.1016/j.jtct.2021.05.001. Transplant Cell Ther. 2021. PMID: 34452721
The third topic in the series focuses on the prevention of cytomegalovirus infection and disease in HCT recipients by reviewing prophylaxis and preemptive therapy approaches; key definitions, relevant risk factors, and diagnostic monitoring considerations are also reviewed …
The third topic in the series focuses on the prevention of cytomegalovirus infection and disease in HCT recipients by reviewing proph …
Delayed-onset cytomegalovirus infection is frequent after discontinuing letermovir in cord blood transplant recipients.
Hill JA, Zamora D, Xie H, Thur LA, Delaney C, Dahlberg A, Pergam SA, Leisenring WM, Boeckh M, Milano F. Hill JA, et al. Among authors: boeckh m. Blood Adv. 2021 Aug 24;5(16):3113-3119. doi: 10.1182/bloodadvances.2021004362. Blood Adv. 2021. PMID: 34402885 Free PMC article.
Cytomegalovirus (CMV)-seropositive umbilical cord blood transplantation (CBT) recipients have a high incidence of CMV-associated complications. ...
Cytomegalovirus (CMV)-seropositive umbilical cord blood transplantation (CBT) recipients have a high incidence of CMV-associated comp …
Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
Casto AM, Seo S, Levine DM, Storer BE, Dong X, Hansen JA, Boeckh M, Martin PJ. Casto AM, et al. Among authors: boeckh m. Blood. 2021 Oct 28;138(17):1628-1636. doi: 10.1182/blood.2021012153. Blood. 2021. PMID: 34269803 Free PMC article.
Human cytomegalovirus (CMV) reactivation is a frequent complication of allogeneic hematopoietic cell transplantation (HCT). ...
Human cytomegalovirus (CMV) reactivation is a frequent complication of allogeneic hematopoietic cell transplantation (HCT). ...
Cytomegalovirus Viremia and Clinical Outcomes in Kenyan Children Diagnosed With Human Immunodeficiency Virus (HIV) in Hospital.
Wamalwa D, Njuguna I, Maleche-Obimbo E, Begnel E, Chebet DJ, Onyango JA, Cranmer LM, Huang ML, Richardson BA, Boeckh M, John-Stewart G, Slyker J. Wamalwa D, et al. Among authors: boeckh m. Clin Infect Dis. 2022 Apr 9;74(7):1237-1246. doi: 10.1093/cid/ciab604. Clin Infect Dis. 2022. PMID: 34214163 Free PMC article.
BACKGROUND: Cytomegalovirus (CMV) viremia is common in human immunodeficiency virus (HIV) infection and is associated with worse long-term outcomes. ...
BACKGROUND: Cytomegalovirus (CMV) viremia is common in human immunodeficiency virus (HIV) infection and is associated with worse long …
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients.
Ljungman P, Bermudez A, Logan AC, Kharfan-Dabaja MA, Chevallier P, Martino R, Wulf G, Selleslag D, Kakihana K, Langston A, Lee DG, Solano C, Okamoto S, Smith LR, Boeckh M, Wingard JR, Cywin B, Fredericks C, Lademacher C, Wang X, Young J, Maertens J. Ljungman P, et al. Among authors: boeckh m. EClinicalMedicine. 2021 Mar 19;33:100787. doi: 10.1016/j.eclinm.2021.100787. eCollection 2021 Mar. EClinicalMedicine. 2021. PMID: 33842870 Free PMC article.
BACKGROUND: Cytomegalovirus (CMV) is a complication of allogeneic haematopoietic cell transplantation (allo-HCT). ...
BACKGROUND: Cytomegalovirus (CMV) is a complication of allogeneic haematopoietic cell transplantation (allo-HCT). ...
165 results